The impact of cyclooxygenase inhibitor use on urinary prostaglandin metabolites in preterm infants

The impact of cyclooxygenase inhibitor use on urinary prostaglandin metabolites in preterm infants

Background: There is limited evidence on the association between the clinical course of patent ductus arteriosus (PDA) and prostaglandin (PG) metabolites. This study aimed to determine the influence of PDA treatment on urinary PG metabolite excretion in very-low-birth-weight (VLBW) infants. Methods:...

Full description

Saved in:
Bibliographic Details
Main Authors: Natsuki Ohkawa, Hiromichi Shoji, Naho Ikeda, Yayoi Murano, Toshiaki Okuno, Masato Kantake, Takehiko Yokomizo, Toshiaki Shimizu
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Pediatrics and Neonatology
Subjects:
cyclooxygenase-2 inhibitor
ductus arteriosus
infant
preterm infant
prostaglandins
Online Access:http://www.sciencedirect.com/science/article/pii/S1875957223001328
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items